Products
Technologies
Applications
Services
Resources
Selection Guides
About
Matrix metalloproteinase 14 Inhibitors (IC50, Ki)
Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
 | Ilomastat | IC50 | 5.2 [1] |
 | (2R)-N-Hydroxy-2-[(4-methoxyphenyl)sulfonyl-(pyridin-3-ylmethyl)amino]-3-methylbutanamide;hydrochloride | IC50 | 23.0 [1] |
 | Batimastat | IC50 | 2.9 [1], 3.0 [2], 4.6 [3], 47.0 [4] |
 | 4-[4-(4-Chloro-phenoxy)-benzenesulfonylmethyl]-tetrahydro-pyran-4-carboxylic acid hydroxyamide | IC50 | 1.1 [1], 14.0 [2] |
 | N-(3-Methoxybenzyl)-4-Oxo-3,4-Dihydroquinazoline-2-Carboxamide | IC50 | 10000.0 [1] |
References
This online resource may be cited as follows
MLA | "Quest Database™ Matrix metalloproteinase 14 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 5 Dec. 2025, https://www.aatbio.com/data-sets/matrix-metalloproteinase-14-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 5). Quest Database™ Matrix metalloproteinase 14 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/matrix-metalloproteinase-14-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |